The arrival of Europeans to the Americas, beginning in the 15th century, all but wiped out the dogs that had lived alongside native people on the continent for thousands of years, according to new research published today in Science.
Patients in intensive care units are at significant risk of potentially life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile. Now, a new test could identify those at greatest risk – and speed up the development of new therapies to help at-risk patients.
Field trials for a vaccine to protect cattle against bovine tuberculosis (bovine TB) would need to involve 500 herds – potentially as many as 75,000-100,000 cattle – to demonstrate cost effectiveness for farmers, concludes a study published today in the journal eLife.
Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.
How fast could a new flu epidemic spread? The results of the UK’s largest citizen science project of its kind ever attempted, carried out by thousands of volunteers, predict that 43 million people in the UK could be infected in an influenza pandemic, and with up to 886,000 of those infected expected to be fatalities.
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs. This discovery, led by researchers at the University of Cambridge, was aided by Eve, an artificially-intelligent ‘robot scientist’.
New research uses innovative data modelling to predict which species acted as an intermediary between our ancestors and those of chimpanzees to carry HSV2 – the genital herpes virus – across the species barrier.
A new app gives UK residents the chance to get involved in an ambitious, ground-breaking science experiment that could save lives.
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.
A new diagnostic test developed from research at the Universities of Cambridge and Dundee has been launched with the aim of helping eliminate the disease known as African sleeping sickness.